• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Striatal D2/acetylcholine interactions: PET studies of the vesamicol receptor.

作者信息

Ingvar M, Stone-Elander S, Rogers G A, Johansson B, Eriksson L, Parsons S M, Widén L

机构信息

Karolinska Hospital, Stockholm, Karolinska, Sweden.

出版信息

Neuroreport. 1993 Sep 30;4(12):1311-4.

PMID:8260611
Abstract

The regional cerebral distribution of [18F]NEFA, an aminobenzovesamicol (ABV), was studied in primates with PET. The binding was stereoselective and could be blocked but not displaced with vesamicol. The regional distribution pattern at late times, striatum > cortex > cerebellum, was corroborated by in vitro autoradiography using [3H]ABV and is consistent with known patterns of cholinergic innervation. Pretreatment with sigma 1 or D1 antagonists did not affect the striatal uptake, whereas D2 antagonists markedly augmented the uptake. This is consistent with the known induction of acetylcholine turnover in the striatum in response to D2-receptor blockade and demonstrates that the amount of [18F]-(-)-NEFA incorporated was influenced by the cholinergic activity in the target neurones.

摘要

相似文献

1
Striatal D2/acetylcholine interactions: PET studies of the vesamicol receptor.
Neuroreport. 1993 Sep 30;4(12):1311-4.
2
Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.多巴胺超敏反应和D1/D2协同作用与纹状体受体密度的变化无关。
Synapse. 1992 Sep;12(1):14-26. doi: 10.1002/syn.890120103.
3
The vesamicol receptor ligand (+)-meta-[125I]iodobenzyltrozamicol [(+)-[125I]-MIBT] reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: possible implications for Parkinson's disease.囊泡乙酰胆碱转运体受体配体(+)-间位-[¹²⁵I]碘苄基曲唑酰胺[(+)-[¹²⁵I]-MIBT]显示,在6-羟基多巴胺(6-OHDA)损伤的大鼠中,纹状体胆碱能对多巴胺D2受体阻断的反应减弱:对帕金森病可能的影响。
Life Sci. 1996;58(16):1367-74. doi: 10.1016/0024-3205(96)00103-8.
4
Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements.对有真空咀嚼运动的大鼠纹状体多巴胺D1、D2及再摄取位点的定量放射自显影术
Brain Res. 1994 May 23;646(2):217-22. doi: 10.1016/0006-8993(94)90081-7.
5
[18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.[18F]氟乙氧基-苯甲酰维司那明,一种用于囊泡乙酰胆碱转运体和胆碱能突触的正电子发射断层显像(PET)放射性示踪剂。
Synapse. 1998 Nov;30(3):263-74. doi: 10.1002/(SICI)1098-2396(199811)30:3<263::AID-SYN4>3.0.CO;2-9.
6
Effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the dopaminergic and cholinergic receptors as evaluated by positron emission tomography in the Rhesus monkey.用正电子发射断层扫描术评估6R-L-赤藓糖型-5,6,7,8-四氢生物蝶呤对恒河猴多巴胺能和胆碱能受体的影响。
J Neural Transm Gen Sect. 1995;102(3):189-208. doi: 10.1007/BF01281154.
7
Effect of Dopamine D Receptor Antagonists on [F]-FEOBV Binding.多巴胺 D 受体拮抗剂对 [F]-FEOBV 结合的影响。
Mol Pharm. 2020 Mar 2;17(3):865-872. doi: 10.1021/acs.molpharmaceut.9b01129. Epub 2020 Feb 17.
8
Age-related diminution of dopamine antagonist-stimulated vesamicol receptor binding.
J Nucl Med. 1996 Jul;37(7):1192-7.
9
The impact of dopamine D-like agonist/antagonist on [F]VAT PET measurement of VAChT in the brain of nonhuman primates.多巴胺 D 样激动剂/拮抗剂对非人类灵长类动物脑内[F]VAT PET 测量 VAChT 的影响。
Eur J Pharm Sci. 2020 Feb 15;143:105152. doi: 10.1016/j.ejps.2019.105152. Epub 2019 Nov 15.
10
Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.纹状体多巴胺 D1 和 D2 受体:对甲基苯丙胺诱导的多巴胺和 5-羟色胺神经毒性的广泛影响。
Synapse. 2011 Nov;65(11):1144-55. doi: 10.1002/syn.20952. Epub 2011 Aug 31.

引用本文的文献

1
No Dopamine Agonist Modulation of Brain [F]FEOBV Binding in Parkinson's Disease.帕金森病患者脑内[F]FEBOV 结合无多巴胺激动剂调节作用。
Mol Pharm. 2022 Apr 4;19(4):1176-1182. doi: 10.1021/acs.molpharmaceut.1c00961. Epub 2022 Mar 15.
2
Effect of Dopamine D Receptor Antagonists on [F]-FEOBV Binding.多巴胺 D 受体拮抗剂对 [F]-FEOBV 结合的影响。
Mol Pharm. 2020 Mar 2;17(3):865-872. doi: 10.1021/acs.molpharmaceut.9b01129. Epub 2020 Feb 17.
3
The impact of dopamine D-like agonist/antagonist on [F]VAT PET measurement of VAChT in the brain of nonhuman primates.
多巴胺 D 样激动剂/拮抗剂对非人类灵长类动物脑内[F]VAT PET 测量 VAChT 的影响。
Eur J Pharm Sci. 2020 Feb 15;143:105152. doi: 10.1016/j.ejps.2019.105152. Epub 2019 Nov 15.
4
In Vivo and In Vitro Characteristics of Radiolabeled Vesamicol Analogs as the Vesicular Acetylcholine Transporter Imaging Agents.放射性标记的 Vesamicol 类似物作为囊泡乙酰胆碱转运蛋白成像剂的体内和体外特征。
Contrast Media Mol Imaging. 2018 Jun 13;2018:4535476. doi: 10.1155/2018/4535476. eCollection 2018.
5
Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates.新型用于非人灵长类动物中囊泡乙酰胆碱转运体(VAChT)的C-11正电子发射断层显像(PET)示踪剂的动力学建模与占有率研究
Nucl Med Biol. 2016 Feb;43(2):131-9. doi: 10.1016/j.nucmedbio.2015.11.003. Epub 2015 Nov 7.
6
In vitro and in vivo characterization of two C-11-labeled pet tracers for vesicular acetylcholine transporter.两种用于囊泡乙酰胆碱转运体的C-11标记PET示踪剂的体外和体内特性研究
Mol Imaging Biol. 2014 Dec;16(6):773-80. doi: 10.1007/s11307-014-0749-9.
7
Multiple protonation states of vesicular acetylcholine transporter detected by binding of [3H]vesamicol.通过[3H]维斯阿米醇结合检测到的囊泡乙酰胆碱转运体的多种质子化状态
Biochemistry. 2009 Sep 29;48(38):8965-75. doi: 10.1021/bi900759v.